Treatment for pheochromocytoma involves blood pressure medications followed by surgery, usually laparoscopic (minimally invasive) removal of one or both adrenal glands. Cushing’s syndrome is a ...
The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback